Clinical trial
ERic Acute StrokE Recanalization (ERASER)
NCT02534701 is registered in ClinicalTrials.gov with Universitätsklinikum Hamburg-Eppendorf as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- ERic Acute StrokE Recanalization (ERASER)
- Lead sponsor
- Universitätsklinikum Hamburg-Eppendorf
- Phase
- Observational
- Overall status
- Completed
- Start date
- May 31, 2015
- Completion date
- July 31, 2017
- Enrollment
- 53 (actual)
- Sites
- 9
Conditions
As the registry lists them; a condition with its own page is linked.